nach oben

Investigational New Drugs

Erschienen in:

28.05.2018 | PRECLINICAL STUDIES

Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer

verfasst von: Maha M. Eissa, Cherine A. Ismail, Mervat Z. El-Azzouni, Amany A. Ghazy, Mona A. Hadi

Erschienen in: Investigational New Drugs | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Summary

Considerable evidence indicates a negative correlation between the prevalence of some parasitic infections and cancer and their interference with tumor growth. Therefore, parasitic antigens seem to be promising candidates for cancer immunotherapy. In this study, the therapeutic efficacy of autoclaved Schistosoma mansoni and Trichinella spiralis antigens against a colon cancer murine model was investigated. Both antigens showed immunomodulatory potential, as evidenced by a significant decrease in serum IL-17, a significant increase in serum IL-10, and the percentage of splenic CD4⁺T-cells and intestinal FoxP3⁺ Treg cells. However, treatment with S. mansoni antigen yielded protection against the deleterious effect of DMH-induced colon carcinogenesis only, with a significant decrease in the average lesion size and number of neoplasias per mouse. For the first time, we report an inhibitory effect of S. mansoni antigen on the progression of chemically induced colon carcinogenesis, but the exact mechanism has yet to be clarified. This anti-tumor strategy could introduce a new era of medicine in which a generation of anticancer vaccines of parasitic origin would boost the therapy for incurable cancers.

Finn JO (2003) Cancer vaccines: between the idea and the reality. Nat Rev Immunol 3:630–641CrossRefPubMed

Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480(7378):480–489CrossRefPubMedPubMedCentral

Darani HY, Yousefi M (2012) Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy. Future Oncol 8(12):1529–1535CrossRefPubMed

Akgül H, Tez M, Ünal AE, Keşkek M, Sayek I, Özçelik T (2003) Echinococcus against cancer: why not? Cancer 198(9):1999–2000. https://doi.org/10.1002/cncr.11752 CrossRef

Chen L, He Z, Qin L, Li Q, Shi X, Zhao S, et al (2011) Antitumor effect of malaria parasite in a murine lewis lung cancer model through induction of innate and adaptive immunity. PLoS ONE 6(9), Article ID e24407

Kang Y, Jo J, Cho M, Yu H, Leem S, Song KS et al (2013) Trichinella spiralis infection reduces tumor growth and metastasis of B16-F10 melanoma cells. Vet Parasitol 196:106–113CrossRefPubMed

Zou J, Huang XX, Yin GW, Ding Y, Liu XY, Wang H, Chen QJ, Suo X (2011) Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts. Parasit Vectors 4:168CrossRefPubMedPubMedCentral

Ubillos L, Freire T, Berriel E, Chiribao ML, Chiale C, Festari MF, Medeiros A, Mazal D, Rondán M, Bollati-Fogolín M, Rabinovich GA, Robello C, Osinaga E (2016) Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers. Int J Cancer 138:1719–1731CrossRefPubMed

Eissa MM, Allam SR, El-Mahdi AR, El-Azzouni MZ (2000) Autoclaved cercarial vaccine against schistosomiasis: ultrastructural and biochemical analysis. Southeast Asian J Trop Med Public Health 31(1):8–15 11414466PubMed

10.

Eissa MM, El-Azzouni MZ, Mady RF, Fathy FM, Baddour NM (2012) Initial characterization of an autoclaved toxoplasma vaccine in mice. Exp Parasitol 131:310–316. https://doi.org/10.1016/j.exppara.2012.05.001 CrossRefPubMed

11.

Eissa MM, Allam SR, El-Azzouni MZ, Maged HR, Dessouky IS (2003) Further studies on autoclaved cercarial vaccine against schistosomiasis safety, longevity and stability. J Egypt Soc Parasitol 33:541–560PubMed

12.

Hakomori S (2003) Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491:369–402CrossRef

13.

Baldus SE, Engelmann K, Hanisch FG (2004) MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit Rev Clin Lab Sci 41(2):189–231CrossRefPubMed

14.

Eissa MM, El-Azzouni MZ, Bolous LM (2003) Vaccination trial against experimental trichinosis using autoclaved Trichinella spiralis larva vaccine. J Egypt Soc Parasitol 33:219–228PubMed

15.

Yang X, Yang Y, Wang Y, Zhan B, Gu Y, Cheng Y, Zhu X (2014) Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice. PLoS One 9(5):e96454. https://doi.org/10.1371/journal.pone.0096454 CrossRefPubMedPubMedCentral

16.

Pellegrino J, Katz N (1968) Experimental chemotherapy of schistosomiasis mansoni. Adv Parasitol 6:233–290CrossRefPubMed

17.

Pica-Mattoccia L, Cioli D (2004) Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 34:27–533CrossRef

18.

Wasson DL, Dougherky DA, Dick TA (1988) T. Spiralis induced by different Trichinella isolates. J Parasitol 74(2):283–287CrossRef

19.

El-Aswad BW, Doenhoff MJ, El Hadidi AS, Schwaeble WJ, Lynch NJ (2011) Use of recombinant calreticulin and cercarial transformation fluid (CTF) in the serodiagnosis of Schistosoma mansoni. Immunobiology 216(3):379–385. https://doi.org/10.1016/j.imbio.2010.06.014

20.

Eissa MM, Mostafa DK, Ghazy AA, El-azzouni MZ, Boulos LM, Younis LK (2016) Anti- arthritic activity of Schistosoma mansoni and Trichinella Spiralis derived-antigens in adjuvant arthritis in rats: role of FOXP3⁺ Treg cells. PLoS One 11(11):e0165916. https://doi.org/10.1371/journal.pone.0165916 CrossRefPubMedPubMedCentral

21.

Lowry OH, Rosebrough NS, Fan AL, Randall RS (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

22.

Thurnherr N, Deschner EE, Stonehill EH, Lipkin M (1973) Induction of adenocarcinomas of the Colon in mice by weekly injections of 1,2-Dimethylhydrazine. Cancer Res 33:940–945PubMed

23.

Darani HY, Curtis RH, McNeice C, Price HP, Sayers JR, Doenhoff MJ (1997) Schistosoma mansoni: anomalous immunogenic properties of a 27 kDa larval serine protease associated with protective immunity. Parasitology 115(3):237–247CrossRefPubMed

24.

Wang XL, Fu BQ, Yang SJ, Wu XP, Cui GZ, Liu MF, Zhao Y, Yu YL, Liu XY, Deng HK, Chen QJ, Liu MY (2009) Trichinella spiralis-A potential anti-tumor agent. Vet Parasitol 159:249–252CrossRefPubMed

25.

Piatier-Tonneau D (2002) CD Guide: CD4. In Mason D, Andre P, Bensussan A, Buckley C, Civin C & Clark E, et al. (Eds) Leucocyte typing VII. White cell differentiation antigens. Proceedings of the 7th International Workshop and Conference. Harrogate, United Kingdom, 19–23 June 2002; New York, Oxford University Press

26.

Alberici P (2007) The adenoma-carcinoma sequence in colorectal Cancer: scratching the surface. PrintPartners Ipskamp, Enschede, The Netherlands Library of the University of Oregon

27.

Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD (2001) Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 61:5389–5395PubMed

28.

Kim M, Grimmig T, Grimm M, Lazariotou M, Meier E, Rosenwald A, Tsaur I, Blaheta R, Heemann U, Germer CT, Waaga-Gasser AM, Gasser M (2013) Expression of Foxp3 in colorectal Cancer but not in Treg cells correlates with disease progression in patients with colorectal Cancer. PLoS One 8(1):e53630CrossRefPubMedPubMedCentral

29.

Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gönner U, Wilsberg V, Junginger T, Berger MR, Galle PR, Moehler M (2005) Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behaviour of human colorectal cancer. Clin Cancer Res 11:1743–1750CrossRefPubMed

30.

Mougiakakos D (2011) Regulatory T cells in colorectal cancer: from biology to prognostic relevance. Cancers (Basel) 3(2):1708–1731. https://doi.org/10.3390/cancers3021708 CrossRef

31.

Salim OE, Hamid HK, Mekki SO, Suleiman SH, Ibrahim SZ (2010) Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World J Surg Oncol 8:68. https://doi.org/10.1186/1477-7819-8-68 CrossRef

32.

Matisz CE, McDougall JJ, Sharkey KA, McKay DM (2011) Helminth parasites and the modulation of joint inflammation. J Parasitol Res 942616

33.

Ladoire S, Martin F, Ghiringhelli F (2011) Prognostic role of FOXP3⁺ regulatory T-cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60:909–918CrossRefPubMed

34.

Ondondo B, Jones E, Godkin A, Gallimore A (2013) Home sweet home: the tumor microenvironment as a haven for regulatory T cells. Front Immunol 4(197)

35.

Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA (2004) The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172:3157–3166CrossRefPubMed

36.

Marinho FV, Alves CC, de Souza SC, da Silva CM, Cassali GD, Oliveira SC et al (2016) Schistosoma mansoni tegument (Smteg) induces IL-10 and modulates experimental airway inflammation. PLoS One 11(7):e0160118CrossRefPubMedPubMedCentral

37.

Amedei A, Niccolai E, Benagiano M, Della Bella C, Cianchi F, Bechi P, Taddei A, Bencini L, Farsi M, Cappello P, Prisco D, Novelli F, D’Elios MM (2013) Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. Cancer Immunol Immunother 62:1249–1260CrossRefPubMed

38.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R et al (2006) Cd4⁺ cd25⁺ foxp3⁺ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS One 1:e129CrossRefPubMedPubMedCentral

39.

Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S (2010) Tumor-infiltrating t-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222:350–366CrossRefPubMedPubMedCentral

40.

Wu D, Wu P, Huang Q, Liu Y, Ye J, Huang J (2013) Interleukin-17: a promoter in colorectal Cancer progression. Clin Dev Immunol 2013:436307. https://doi.org/10.1155/2013/436307 CrossRefPubMedPubMedCentral

41.

Urban JF, Katona IM, Paul WE, Finkelman FD (1991) Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc Natl Acad Sci U S A 88(13):5513–5517CrossRefPubMedPubMedCentral

42.

Xu Y, Pasche B (2007) TGF-β signalling alterations and susceptibility to colorectal cancer. Hum Mol Genet 16(SPEC):R14–R20. https://doi.org/10.1093/hmg/ddl486 CrossRefPubMedPubMedCentral

43.

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favourable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102:18538–18543CrossRefPubMedPubMedCentral

44.

Berriel E, Hill M, Barcia JJ, Ubillos L, Gonza’lez M, Detjen G et al (2005) Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Oncol Rep 14:219–228PubMed

45.

Brockhausen I (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7:599–604CrossRefPubMedPubMedCentral

46.

Thors C, Jansson B, Helin H, Linder E (2006) Thomsen-Friedenreich oncofetal antigen in Schistosoma mansoni: localization and immunogenicity in experimental mouse infection. Parasitology 132:73–81CrossRefPubMed

47.

Wolf DA, Wang S, Panzica MA, Bassily NH, Thompson NL (1996) Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56:5012–5022PubMed

48.

Ortega-Pierres MG, Yepez-Mulia L, Homan W, Gamble HR, Lim PL, Takahashi Y et al (1996) Workshop on a detailed characterization of Trichinella spiralis antigens: a platform for future studies on antigens and antibodies to this parasite. Parasite Immunol 18(6):273–284CrossRefPubMed

Titel: Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer
verfasst von: Maha M. Eissa
Cherine A. Ismail
Mervat Z. El-Azzouni
Amany A. Ghazy
Mona A. Hadi
Publikationsdatum: 28.05.2018
Verlag: Springer US
Erschienen in: Investigational New Drugs / Ausgabe 1/2019
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI: https://doi.org/10.1007/s10637-018-0609-6

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer

Summary

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors

Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma

Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate

The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer

Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists

A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie